MarkWide Research

Sale!

Colorectal Cancer Screening Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2023-2030

Published Date: December, 2022
No of Pages: 164
Delivery Format: PDF+ Excel

$2,950.00

According to a new report by Grand View Research, the global colorectal cancer screening market is expected to reach USD 10.7 billion by 2025. This growth is primarily driven by the rising incidence of colorectal cancer and the growing awareness about the importance of early detection and treatment of the disease.

In addition, the introduction of new screening technologies, such as colonoscopy and stool-based tests, is expected to drive market growth over the forecast period. However, the high cost of screening procedures and the lack of awareness about the disease in developing countries are expected to restrain market growth in the coming years.

The global colorectal cancer screening market is segmented on the basis of technology, end user, and geography.

On the basis of technology, the market is segmented into colonoscopy, stool-based tests, flexible sigmoidoscopy, computed tomography colonography, and others. Among these, colonoscopy is the most widely used screening method as it allows for the direct visualisation of the colon and the identification and removal of precancerous lesions.

On the basis of end users, the market is segmented into hospitals, clinics, and others. The hospital segment is expected to grow at the fastest rate over the forecast period owing to the increasing number of colorectal cancer cases and the availability of sophisticated infrastructure and trained personnel.

On the basis of geography, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to remain the dominant market over the forecast period owing to the high incidence of colorectal cancer, the availability of advanced healthcare infrastructure, and the growing awareness about the importance of early detection and treatment of the disease.

The Asia Pacific region is expected to witness the fastest growth over the forecast period owing to the growing awareness about the disease, the increasing incidence of colorectal cancer, and the availability of advanced healthcare infrastructure.

Some of the key players operating in the global colorectal cancer screening market are F. Hoffmann-La Roche Ltd., Siemens Healthcare, GE Healthcare, Philips Healthcare,

2. Colorectal Cancer Screening Market Challenges
Colorectal cancer is the third most common cancer in the world. Despite this, the market for colorectal cancer screening is still relatively small. This is because there are a number of challenges that need to be overcome in order for the market to grow.

The first challenge is that there is a lack of awareness of the importance of screening for colorectal cancer. This is particularly true in developing countries, where the prevalence of the disease is high but awareness is low. In developed countries, there is generally a higher awareness of the importance of screening, but there is still a significant proportion of the population that is not screened.

The second challenge is that there is a lack of effective screening tests. The most common test used for colorectal cancer screening is the colonoscopy. However, this test is not always accurate and can often miss early-stage cancer. This means that people may not be diagnosed with the disease until it is too late.

The third challenge is the cost of screening. Colonoscopies can be expensive and are not always covered by insurance. This can make it difficult for people to get screened, particularly in developing countries.

Despite these challenges, the market for colorectal cancer screening is expected to grow in the coming years. This is due to the increasing awareness of the importance of screening and the development of new, more effective screening tests.

3. Colorectal Cancer Screening Market Key Trends
Colorectal cancer is the third most common cancer in the world. Despite this, it is one of the most preventable cancers with screening tests that can detect precancerous polyps so they can be removed before they turn into cancer.

There are several different types of colorectal cancer screening tests, each with its own pros and cons. The three most common types of tests are colonoscopy, sigmoidoscopy, and stool tests.

The colonoscopy is the most comprehensive and accurate of the three tests. It involves inserting a long, flexible tube with a camera into the rectum and colon to look for polyps or cancer. The entire procedure takes about 30 minutes and is usually done under sedation.

Sigmoidoscopy is similar to colonoscopy, but the scope is shorter and only examines the lower part of the colon. This test is less invasive than a colonoscopy and takes less time, but it is also less accurate.

Stool tests are the simplest and most non-invasive of the three tests. They involve collecting a stool sample and testing it for blood or other abnormalities that could be indicative of cancer. There are several different types of stool tests, and they can be done at home with a kit.

All three of these tests have their own pros and cons, and the best one for each individual will depend on several factors. Age, health history, and personal preferences all play a role in deciding which test is best.

No matter which test is used, colorectal cancer screening is an important part of staying healthy and preventing cancer.

Colorectal Cancer Screening Market Report Scope and Segmentation
ATTRIBUTESDETAILS
ESTIMATED YEAR2023
BASE YEAR2022
FORECAST YEAR2030
HISTORICAL YEAR2017-2022
UNITValue (USD Million/Billion)
BY REGIONNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

4. Colorectal Cancer Screening Market COVID19 Impact
The outbreak of the COVID-19 pandemic has had a significant impact on the healthcare industry globally. The colorectal cancer screening market is no exception. The market is expected to experience a significant decline in the short term due to the pandemic.

The COVID-19 pandemic has led to a slowdown in the global economy and has had a negative impact on various industries. The healthcare industry has been particularly affected by the pandemic. Hospitals and clinics have been overwhelmed with patients suffering from the virus. This has led to a decline in the number of elective procedures being performed. Elective procedures, such as colorectal cancer screenings, are often postponed or cancelled in times of crisis, such as the current pandemic.

The decline in the number of elective procedures being performed has had a direct impact on the colorectal cancer screening market. The market is expected to experience a significant decline in the short term due to the pandemic. However, it is expected to recover in the long term, as the number of elective procedures is expected to increase once the pandemic is over.

5. Colorectal Cancer Screening Market: Key Industry Developments
Colorectal cancer is the third most common cancer in the world. Every year, it affects more than 1.4 million people and kills over 600,000. In the United States, it is the second-leading cause of cancer death after lung cancer.

Screening is one of the most effective ways to prevent colorectal cancer. It can detect precancerous polyps and remove them before they become cancerous.Screening can also find colorectal cancer early, when it is most likely to be curable.

There are several different types of colorectal cancer screening tests. Some of the most common are colonoscopy, sigmoidoscopy, and stool tests.

Colonoscopy is the most effective screening test for colorectal cancer. It is a procedure in which a doctor inserts a long, flexible tube with a camera into the rectum and colon. The doctor can then look for polyps or other abnormal growths. If any are found, they can be removed during the procedure.

Sigmoidoscopy is similar to colonoscopy, but the tube is not inserted as far into the colon. This procedure can usually be done in a doctor’s office.

Stool tests look for blood in the stool, which can be a sign of colorectal cancer. There are two types of stool tests:

Fecal occult blood test (FOBT): This test checks for hidden (occult) blood in three consecutive stool samples.

Fecal immunochemical test (FIT): This test checks for hidden blood in a single stool sample.

Screening for colorectal cancer is recommended for all adults starting at age 50. People with certain risk factors, such as a family history of colorectal cancer, may need to start screening earlier.

There are several key industry developments related to colorectal cancer screening.

In 2014, the U.S. Food and Drug Administration (FDA) approved a new stool test, called Cologuard. This test is used to screen for colorectal cancer.

Test type
  • Fecal Occult Blood Tests
  • Biomarker Tests
  • CRC DNA Screening Tests
  Imaging type
  • Colonoscopy
  • Proctoscopy
  • CT Scan
  • Ultrasound
  • MRI
  • PET Scan
  End users
  • Hospitals
  • Clinics
  • Diagnostics Laboratories
  • Eiken Chemical Co Ltd
  • Sentinel CH. SpA
  • Alfresa Pharma Corp
  • Showa Denko Materials Co Ltd
  • Danaher Corp
  • Hemosure Inc
  • Medline Industries Inc
  • QuidelOrtho Corp
  • Sekisui Diagnostics LLC
  • Epigenomics AG
  • Exact Sciences Corp
  • Aerscher Diagnostics LLC
  • Thermo Fisher Scientific Inc
  • Boditech Med Inc
  • McKesson Corp
  • Propper Manufacturing Co Inc

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF